BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

886 related articles for article (PubMed ID: 15380542)

  • 1. Tolerance induction in clinical transplantation.
    Fehr T; Sykes M
    Transpl Immunol; 2004; 13(2):117-30. PubMed ID: 15380542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donor stem cell infusion after non-myeloablative conditioning for tolerance induction to HLA mismatched adult living-donor liver graft.
    Donckier V; Troisi R; Toungouz M; Colle I; Van Vlierberghe H; Jacquy C; Martiat P; Stordeur P; Zhou L; Boon N; Lambermont M; Schandené L; Van Laethem JL; Noens L; Gelin M; de Hemptinne B; Goldman M
    Transpl Immunol; 2004; 13(2):139-46. PubMed ID: 15380544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor bone marrow transplantation: chimerism and tolerance.
    Delis S; Ciancio G; Burke GW; Garcia-Morales R; Miller J
    Transpl Immunol; 2004; 13(2):105-15. PubMed ID: 15380541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The road to tolerance: renal transplant tolerance induction in nonhuman primate studies and clinical trials.
    Elster EA; Hale DA; Mannon RB; Cendales LC; Swanson SJ; Kirk AD
    Transpl Immunol; 2004; 13(2):87-99. PubMed ID: 15380539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From current immunosuppressive strategies to clinical tolerance of allografts.
    Golshayan D; Buhler L; Lechler RI; Pascual M
    Transpl Int; 2007 Jan; 20(1):12-24. PubMed ID: 17181648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S
    Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous protection against allograft rejection and graft-versus-host disease after total lymphoid irradiation: role of natural killer T cells.
    Liu YP; Li Z; Nador RG; Strober S
    Transplantation; 2008 Feb; 85(4):607-14. PubMed ID: 18347541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The beginning of clinical tolerance in solid organ allografts.
    Monaco AP
    Exp Clin Transplant; 2004 Jun; 2(1):153-61. PubMed ID: 15859922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation.
    Heinzelmann F; Lang PJ; Ottinger H; Faul C; Bethge W; Handgretinger R; Bamberg M; Belka C
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):523-8. PubMed ID: 17869449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixed chimerism achieved by a nonlethal conditioning regimen induces donor-specific tolerance to lung allografts.
    Li S; Salgar SK; Kurimoto Y; Yousem S; Pham SM
    J Surg Res; 2008 May; 146(2):289-97. PubMed ID: 18314139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total lymphoid irradiation.
    Sutherland DE; Ferguson RM; Simmons RL; Kim TH; Slavin S; Najarian JS
    Urol Clin North Am; 1983 May; 10(2):277-88. PubMed ID: 6344387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with immunotoxin.
    Knechtle SJ
    Philos Trans R Soc Lond B Biol Sci; 2001 May; 356(1409):681-9. PubMed ID: 11375071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The concept of "partial" clinical tolerance.
    Cortesini R; Suciu-Foca N
    Transpl Immunol; 2004; 13(2):101-4. PubMed ID: 15380540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolutionary experience with immunosuppression in pediatric intestinal transplantation.
    Bond GJ; Mazariegos GV; Sindhi R; Abu-Elmagd KM; Reyes J
    J Pediatr Surg; 2005 Jan; 40(1):274-9; discussion 279-80. PubMed ID: 15868597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental study of immunological tolerance induced by cytotoxic T lymphocyte-associated antigen 4 immunoglobulin in fresh bone allografts].
    Guo C; Dai K; Tang T
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2005 May; 19(5):381-5. PubMed ID: 15960444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation.
    Kuo YR; Huang CW; Goto S; Wang CT; Hsu LW; Lin YC; Yang KD; Chen CL; Lee WP
    J Surg Res; 2009 May; 153(2):317-25. PubMed ID: 19101689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune responses and their regulation by donor bone marrow cells in clinical organ transplantation.
    Mathew JM; Garcia-Morales RO; Carreno M; Jin Y; Fuller L; Blomberg B; Cirocco R; Burke GW; Ciancio G; Ricordi C; Esquenazi V; Tzakis AG; Miller J
    Transpl Immunol; 2003; 11(3-4):307-21. PubMed ID: 12967784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hurdles to the induction of tolerogenic mixed chimerism.
    Pilat N; Klaus C; Schwaiger E; Wekerle T
    Transplantation; 2009 May; 87(9 Suppl):S79-84. PubMed ID: 19424016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
    Galili U
    Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.